Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
884.00    -2.00 (-0.23%)
Bid:
882.00
Ask:
884.00
Spread: 2.00 (0.227%)
Market Cap: £832.25m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AuM Update

9 Jul 2026 07:00

RNS Number : 6021L
Polar Capital Holdings PLC
09 July 2026
 

9 July 2026

Polar Capital Holdings plc

AuM Update

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist active asset manager, provides below a quarterly, unaudited summary of its Assets under Management ("AuM").

 

Group AuM (unaudited)

 

Polar Capital reports that as at 30 June 2026 its AuM was £45.0bn compared to £30.6bn at the end of March 2026, an increase of 47% over the quarter. In the quarter, AuM increased by net inflows of £2.5bn and fund performance and market movements of £11.9bn.

 

AuM movement in three months to 30 June 2026

Open ended

Funds

(£m)

Investment

Trusts

(£m)

Segregated Mandates

(£m)

Total

(£m)

AuM at 1 April 2026

23,424

6,605

604

30,633

Net flows

2,412

(46)

94

2,460

Market movement

and fund performance

8,737

3,035

128

11,900

Total AuM at 30 June 2026

34,573

9,594

826

44,993

 

 

Iain Evans, Chief Executive, commented:

 

"Momentum has continued since the 19 June AuM update included in our Annual Results announcement, with Group AuM of £45.0bn as at 30 June 2026, up 47% from £30.6bn at 31 March 2026. This reflected net inflows of £2.5bn and positive market movements and investment performance of £11.9bn over the quarter. Strong absolute and relative performance from our Technology, Artificial Intelligence and Smart Energy strategies was a key contributor, supported by high-conviction thematic positioning.

 

"Client demand was led by our Technology and AI funds, with positive contributions from Healthcare, Smart Energy, Global Absolute Return and Japan Value. Net outflows were primarily from Emerging Markets Stars and Global Insurance, with redemptions remaining largely client specific.

 

"We continue to see a supportive environment for specialist active management, as markets broaden and elevated stock-level dispersion strengthens the case for high-conviction, differentiated strategies.

 

"This progress provides a strong start to the new financial year. With significant fund capacity across our diverse range of specialist active strategies, we remain focused on converting client demand into durable net flows and delivering long-term value for clients and shareholders."

 

 

 

For further information please contact:

 

Polar Capital

Iain Evans (Chief Executive)Samir Ayub (Chief Financial Officer)

+44 (0)20 7227 2700

 

Deutsche Numis - Nomad and Joint Broker

Charles Farquhar

Duncan Monteith

Rajesh Iyer

 

 

+44 (0)20 7545 8000

 

 

Peel Hunt LLP - Joint Broker

Andrew Buchanan

Thomas Philpott

 

 

+44 (0)20 3597 8680

Camarco - PR

Ed Gascoigne-Pees

Jennifer Renwick

Phoebe Pugh

+44 (0)20 3757 4980

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEANXPEFLKEFA
Date   Source Headline
26th Mar 20251:01 pmRNSHolding(s) in Company
25th Mar 20258:32 amRNSDirector/PDMR Shareholding
4th Mar 20259:44 amRNSHolding(s) in Company
3rd Feb 20253:34 pmRNSBlock listing Interim Review
28th Jan 20259:33 amRNSDirector/PDMR Shareholding
22nd Jan 20252:05 pmRNSHolding(s) in Company
22nd Jan 20251:44 pmRNSDirector/PDMR Shareholding
17th Jan 202511:07 amRNSDirector/PDMR Shareholding
16th Jan 20252:43 pmRNSForm 8.3 - Direct Line Insurance Group PLC
15th Jan 20252:24 pmRNSForm 8.3 - Direct Line Insurance Group PLC
14th Jan 20254:28 pmRNSForm 8.3 - Direct Line Group PLC
13th Jan 20257:00 amRNSAuM Update
24th Dec 202410:36 amRNSForm 8.3 - Direct Line Insurance Group PLC
23rd Dec 20245:11 pmRNSForm 8.3 - Intelligent Ultrasound Group PLC Amend
23rd Dec 202412:20 pmRNSForm 8.3 - Intelligent Ultrasound Group PLC
2nd Dec 202411:43 amRNSTotal Voting Rights
29th Nov 20244:54 pmRNSForm 8.3 - Direct Line Insurance Group PLC
26th Nov 202410:02 amRNSHolding(s) in Company
18th Nov 20247:00 amRNSUnaudited Interim Results
12th Nov 20249:14 amRNSCrystallisation of Business Unit & Issue of Shares
31st Oct 20247:00 amRNSNotice of Results
10th Oct 20247:00 amRNSAuM Update
26th Sep 20243:54 pmRNSReplacement: Result of AGM
25th Sep 20243:43 pmRNSResult of AGM
16th Aug 20242:08 pmRNSForm 8.3 - RENALYTIX PLC
15th Aug 202412:37 pmRNSForm 8.3 - RENALYTIX PLC
13th Aug 20243:08 pmRNSForm 8.3 - RENALYTIX PLC
5th Aug 20241:44 pmRNSBlock listing Interim Review
1st Aug 20249:16 amRNSDirector/PDMR Shareholding
22nd Jul 20244:53 pmRNSDirector/PDMR Shareholding
18th Jul 20244:56 pmRNSHolding(s) in Company
15th Jul 202411:04 amRNSDirector/PDMR Shareholding
11th Jul 20249:49 amRNSForm 8.3 - CREST NICHOLSON HOLDINGS PLC
11th Jul 20247:00 amRNSAuM Update
4th Jul 20246:23 pmRNSDirector/PDMR Shareholding
2nd Jul 20245:05 pmRNSHolding(s) in Company
27th Jun 20241:15 pmRNSGroup Audited Results for year ended 31 March 2024
27th Jun 20247:00 amRNSGroup Audited Results for year ended 31 March 2024
17th Jun 20243:37 pmRNSForm 8.3 - CREST NICHOLSON HOLDINGS
3rd Jun 20246:16 pmRNSTotal Voting Rights
3rd Jun 20241:56 pmRNSTotal Voting Rights
22nd May 20249:12 amRNSIssue of Equity
15th May 202410:06 amRNSDirector/PDMR Shareholding
13th May 20245:49 pmRNSHolding(s) in Company
13th May 20243:34 pmRNSHolding(s) in Company
26th Apr 202410:33 amRNSForm 8.3 - RENALYTIX PLC
17th Apr 20243:55 pmRNSDirector/PDMR Shareholding
12th Apr 20245:43 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSAuM Update
9th Apr 20244:01 pmRNSChange of Company Secretary

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.